Learn about four common precancerous conditions, their causes, warning signs, and preventive measures to manage risks and ...

Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), has entered into a strategic partnership with VITALExam, a comprehensive medical care ...

The company — which was launched in 2018 as a subsidiary of medtech company PAVmed — has developed a quick, office-based test that can detect precancer in people with heartburn at risk of ...

Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This method could be important for enhancing cervical ...

Emily Fukuchi, MD; Barbara Fetterman, SCT (ASCP); Nancy Poitras, ACS, PMP; Walter Kinney, MD; Thomas Lorey, MD; Ramey D. Littell, MD To evaluate whether the presence of CIN 1 on ECC contributes to ...

The company also recently published multiple new clinical validation studies to support its quest for reimbursement.

It was found that 71 of these women (8.3%) had the severe cervical precancer or cancer. The researchers looked at the details of the HPV test results on self-sample and used a new method to assess the ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Lucid and VITALExam launched the partnership with a fully-contracted #CheckYourFoodTube Precancer Testing Event at Tuscaloosa Fire Rescue in Tuscaloosa, AL, as part of Lucid's expanded direct ...

Objective. This study aimed to characterize the 24-month risk of cervical intraepithelial neoplasia grade 2 or worse (CIN 2+) and grade 3 or worse (CIN 3+) in women with low-risk cytological ...

Lucid and VITALExam launched the partnership with a fully-contracted #CheckYourFoodTube Precancer Testing Event at Tuscaloosa Fire Rescue in Tuscaloosa, AL, as part of Lucid's expanded direct ...